Today’s’ podcast is a recording of the Pituitary World News talk program that aired live on November 16. The information comes directly from one of the busiest, most successful clinics in the world of pituitary disease. The podcast presents a real-world, honest, in-depth discussion of health insurance denials, how this practice affects patients and physicians, how they use guidelines to muddy the process, oppose individualized care, and question a specialist’s decision-making.
An informative discussion on the effects of hormones on hair loss, a common occurrence for people dealing with pituitary conditions. In this LIve-talk session, Dr. Blevins discusses the facts and the myths.
On our Live-talk program today, a fascinating, nothing left on the table, discussion about a variety of topics that affect pituitary patients; from access to medication and therapies to problems with social media and misinformation to the complexities of diagnosis and refuting diagnosis to the role of the doctor and the patient to solve many of these challenges.
It’s always fascinating to listen to two of the recognized experts and leading clinicians in Cushing’s disease discuss their experiences with the disease and patients. In this Live Talk session, Pituitary World New’s innovative program for education and awareness, Dr. Kevin Yuen and Dr. Lewis Blevins bring an intimate, revealing look at their approaches to Cushing’s disease and syndrome.
Listen to Dr. Tamara Wexler, a nationally recognized neuroendocrinologist and expert in pituitary dysfunction after a brain injury. She joins Dr. Lewis Blevins in this eye-opening podcast.
Mental health and emotional wellness are essential topics for pituitary patients, their families, and friends. This on-demand session from last Thursday’s live-talk program focuses on the challenges and opportunities when considering these issues.
Decisions made by doctors and their patients can be some of the most complicated, difficult decisions to make. This session focuses on the factors that influence medical decision-making, the impacts those decisions carry, and how the practical clinical aspects of these choices affect our everyday lives.
Semantics, or by definition, the way we relate to different meanings of words or other symbols, are essential. The words we use to communicate and inform are critical. In our session today, we discuss the semantics of pituitary medicine and underline the importance of describing things accurately.
In this podcast, we dive into the world of endocrine nursing with Dr. Chris Yedinak from the Oregon Health and Science University. For the last five years, she has specialized in neuroendocrine testing and pre-and post-operative care of patients with neuroendocrine and pituitary diseases. Nurses play a critical role in the care of patients with pituitary disease and we are delighted to bring you this wonderful conversation.
This session presents more musing based on the actual practice of pituitary medicine, including growth hormone, the recent Covid-19 surge, dexamethasone dose adjustments, an interesting empty sella case with an enlarged pituitary gland, gadolinium, and the connection between mold and pituitary tumors misinformation flying around on the internet, adrenal and pituitary Cushing’s, and a look at telemedicine changes that may not be that good for patients.
Dr. Lewis Blevins talks with guest Dr. Saleh Aldasouqi, Professor, Chief, Division of Endocrinology and Metabolism, and Clinician at Michigan State University Specialty Center, Endocrinology Clinic, about Biotin use and its interference with laboratory tests.
Our live talk session from May 12 is now available on-demand with guests Jill Sisco, president of the Acromegaly Community, and Sharmyn McGraw from the Pacific Neuroscience Institute. This was a fascinating perspective on the challenges and opportunities for patient advocacy programs.
A highly informational “live-talk” session from Dr. Blevins about the indications for pituitary surgery for patients with pituitary adenomas, and critical information for patients with Central Adrenal Insufficiency due to hypothalamic or pituitary disease.